20-32436374-C-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_015338.6(ASXL1):c.3662C>A(p.Thr1221Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,613,734 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_015338.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASXL1 | NM_015338.6 | c.3662C>A | p.Thr1221Lys | missense_variant | 13/13 | ENST00000375687.10 | NP_056153.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASXL1 | ENST00000375687.10 | c.3662C>A | p.Thr1221Lys | missense_variant | 13/13 | 5 | NM_015338.6 | ENSP00000364839.4 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000216 AC: 54AN: 249498Hom.: 3 AF XY: 0.000281 AC XY: 38AN XY: 135092
GnomAD4 exome AF: 0.000104 AC: 152AN: 1461380Hom.: 7 Cov.: 31 AF XY: 0.000153 AC XY: 111AN XY: 726990
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74504
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 12, 2023 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at